Whole-Brain Radiation Therapy Could Not Improve the Overall Survival of EGFR-Mutant NSCLC Patients with Leptomeningeal Metastasis

被引：0
|
作者：
Yan, W. [1 ]
机构：
[1] Shandong Univ, Shandong Canc Hosp, Jinan, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.2272
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2206
引用
收藏
页码：E92 / E92
页数：1
相关论文
共 50 条
  • [1] Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
    Weiwei Yan
    Yang Liu
    Ji Li
    Anqin Han
    Li Kong
    Jinming Yu
    Hui Zhu
    [J]. Radiation Oncology, 14
  • [2] Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis
    Yan, Weiwei
    Liu, Yang
    Li, Ji
    Han, Anqin
    Kong, Li
    Yu, Jinming
    Zhu, Hui
    [J]. RADIATION ONCOLOGY, 2019, 14 (01)
  • [3] Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases
    Ye, Qiuyue
    Xu, Yan
    Zhao, Jing
    Gao, Xiaoxing
    Chen, Minjiang
    Pan, Ruili
    Zhong, Wei
    Wang, Mengzhao
    [J]. TRANSLATIONAL ONCOLOGY, 2023, 31
  • [4] Aumolertinib Combination Therapy for EGFR-Mutant NSCLC Patients with Refractory Leptomeningeal Metastasis Following Osimertinib Failure
    Ding, H.
    Xu, T.
    Wang, X.
    Cheng, W.
    Fang, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S670 - S671
  • [5] Whole-brain Radiation Therapy for Breast Cancer Patients with Dural Metastasis Without Concomitant Brain Metastasis and Leptomeningeal Metastasis
    Sakaguchi, Masakuni
    Maebayashi, Toshiya
    Aizawa, Takuya
    Ishibashi, Naoya
    [J]. ANTICANCER RESEARCH, 2018, 38 (11) : 6405 - 6411
  • [6] Metachronous Brain Metastasis in patients with EGFR-mutant NSCLC indicates a worse prognosis
    Ouyang, Wen
    Yu, Jing
    Zhou, Yan
    Xu, Yu
    Li, Jie
    Gong, Jun
    Zhang, Junhong
    Xie, Conghua
    [J]. JOURNAL OF CANCER, 2020, 11 (24): : 7283 - 7290
  • [7] Unique Genetic Profiles from Cerebrospinal Fluid Could Predict Survival of EGFR-Mutant NSCLC with Leptomeningeal Metastases
    Li, Y.
    Jiang, B.
    Zheng, M.
    Tu, H.
    Yang, J.
    Zhang, X.
    Ye, J.
    Zhou, Q.
    Zhong, W.
    Zhang, C.
    Chuai, S.
    Wu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S482 - S482
  • [8] Cost-effectiveness of icotinib versus whole-brain irradiation with or without chemotherapy in EGFR-mutant NSCLC patients with brain metastases
    Li, Wenqian
    Bai, Rilan
    Qian, Lei
    Chen, Naifei
    Zhao, Yuguang
    Han, Fujun
    Bai, Ling
    Li, Jiaxuan
    Yu, Yu
    Cui, Jiuwei
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (02) : E40 - E47
  • [9] Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer
    Choi, Mihong
    Keam, Bhumsuk
    Ock, Chan-Young
    Kim, Miso
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    [J]. CLINICAL LUNG CANCER, 2019, 20 (04) : E442 - E451
  • [10] Cost-effectiveness analysis of icotinib versus whole-brain irradiation with or without chemotherapy in EGFR-mutant NSCLC patients with brain metastases.
    Li, Wenqian
    Bai, Rilan
    Qian, Lei
    Chen, Naifei
    Zhao, Yuguang
    Han, Fujun
    Bai, Ling
    Li, Jiaxuan
    Yu, Yu
    Cui, Jiuwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345